4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-042259
EVP, Drug Development gave up 2,012 shares (to pay taxes)
- EVP, Drug Development acquired 5,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2022-07-13 | Option exercise | +1,250 | 12,122 | D: show line 1 in the form | ||
| MANHARD KIMBERLY EVP, Drug Development | 2022-07-13 | Option exercise | +4,564 | 16,686 | D: show line 2 in the form | ||
| MANHARD KIMBERLY EVP, Drug Development | 2022-07-13 | Shares withheld for taxes | −2,012 | $3.01 | $6,056 | 14,674 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2022-07-13 | Option exercise · Restricted Stock Units | −1,250 | 11,250 | D: show line 4 in the form | ||
| MANHARD KIMBERLY EVP, Drug Development | 2022-07-13 | Option exercise · Restricted Stock Units | −4,564 | 41,628 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…